VisionCare Ophthalmic Technologies, Inc. announced that it has secured up to $15 Million in long-term, non-dilutive financing to accelerate the commercialization of its novel therapy. The capital was raised exclusively from Life Sciences Alternative Funding LLC.
Samsara Vision, Inc.
Equities
SMSA
US79600A1051
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
+15.20% | 131B | |
-7.32% | 11.05B | |
-11.58% | 7.71B | |
+41.65% | 5.67B | |
-18.05% | 4.95B | |
+7.99% | 3.43B | |
-19.96% | 2.46B | |
-15.76% | 1.97B | |
-16.68% | 1.85B |